Evidence map›Paper›PMID 37198645›Full record

ArticleAnnals of clinical microbiology and antimicrobials2023

Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities.

Yiwen Liao, Qinghui Xie, Xiaoxiao Li, Xiaona Yin, Xingzhong Wu, Mingjing Liu, Yuying Pan, Lihong Zeng, Jianjiang Yang, Zhanqin Feng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Tetracycline-resistantJAC-antimicrobial resistance · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Rolling the evolutionary dice:Microbiology spectrum · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yiwen Liao *Dermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Qinghui Xie *Dermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Xiaoxiao Li *Dermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Xiaona YinDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Xingzhong WuDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Mingjing LiuDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Yuying PanDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Lihong ZengDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Jianjiang YangDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Zhanqin FengDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China.
Xiaolin QinDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China. 460162606@qq.com.
Heping ZhengDermatology Hospital, Southern Medical University, Lujing Road 2, Yuexiu, Guangzhou, 510091, Guangdong, China. zhengheping@smu.edu.cn.
Southern Medical University · CN

Funding

Key scientific research platforms and research projects of colleges and universities in Guangdong Province 2018KQNCX025National Natural Science Foundation for Young Scholars of China 82104626Overseas famous teacher project, Science and Technology Agency of Guangdong Province 2020A1414010136
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) of untreatable gonococcal infection is an emerging threat, especially in Guangdong, a prosperous province in Southern China.

methodsN.gonorrhoeae was isolated from 20 cities in Guangdong and determined antimicrobial susceptibility. Through whole-genome sequencing (WGS), multilocus sequence typing (MLST), N.gonorrhoeae multiantigen sequence typing (NG-MAST), and N.gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) were obtained based on the PubMLST database ( https://pubmlst.org/ ). Phylogenetic analysis was used for dissemination and tracking analysis.

resultsAntimicrobial susceptibility was performed on 347 isolates, and 50 isolates were identified as decreased susceptibility (DS) to cephalosporins. Of which 16.0% (8/50) were ceftriaxone DS, 38.0% (19/50) were cefixime DS, and 46.0% (23/50) were both ceftriaxone and cefixime DS. In all, the dual-resistant rate of the cephalosporin-DS isolates was 96.0% for penicillin and 98.0% for tetracycline-resistant, and 10.0% (5/50) were resistant to azithromycin. All cephalosporin-DS isolates were resistant to ciprofloxacin but sensitive to spectinomycin. The predominant MLSTs were ST7363 (16%, 8/50), ST1903 (14%, 7/50), ST1901 (12%, 6/50), and ST7365 (10%, 5/50). Besides some isolates that failed genotyping (NA), NG-STAR ST1143 (n = 6) and NG-MAST ST17748 (n = 4) were the most prevalent. Twelve isolates with mosaic penA-60.001 allele retained the most elevated cephalosporin MIC (Minimum Inhibitory Concentration). Phylogenetic analysis revealed that epidemic penA-60.001 clones, either domestic or foreign, had spread to nine cities in Guangdong, and 9/12 clones were from the Pearl River Delta region.

conclusionsN. gonorrhoeae with cephalosporins-DS was extensively disseminated in Guangdong, Southern China, requiring strict surveillance.

Indexed as

CephalosporinsGonorrheaAnti-Bacterial AgentsCefiximeCeftriaxoneCitiesHumansMicrobial Sensitivity TestsMultilocus Sequence TypingNeisseria gonorrhoeaePhylogenyAnti-Bacterial AgentsCefiximeCeftriaxoneCephalosporinsExtended-spectrum cephalosporins (ESCs)Genomic epidemiologyNeisseria gonorrhoeaeResistanceSexually transmitted infectionsWhole-genome sequencing

Identifiers

PMID37198645
PMCPMC10189960
OpenAlexW4377010833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.